Amylyx Pharmaceuticals Secures $5,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d59a98b5-5830-432e-8460-bc154571f6d0
Date
8/24/2016
Company Name
Amylyx Pharmaceuticals
Mailing Address
210 Broadway Cambridge, MA 02139 USA
Company Description
Amylyx is an IND-enabling stage biopharmaceutical company dedicated to providing innovative, disease-modifying solutions for neurodegenerative diseases. We have a highly creative and motivated team focused on streamlined clinical development and drug discovery.
Website
http://www.amylyx.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Series A
Proceeds Purposes
Our investment in Amylyx is aligned with the Fund’s goals of driving medical advancement for this terrible disease.
M&A Terms
Venture Investor
Morningside Group
Venture Investor
Investor